搜索筛选:
搜索耗时0.9150秒,为你在为你在102,267,441篇论文里面共找到 7 篇相符的论文内容
发布年度:
[期刊论文] 作者：Carl C Schimanski Peter R Gall,
来源：世界胃肠病学杂志：英文版（电子版） 年份：2008
为胃肠的癌症考察 CXCR4 的含意，一“ Pubmed' 分析被执行以便为胃肠的癌症评估 CXCR4 和它的 ligands 的关联。使用的搜索词是“癌症， malignoma，食道，胃，结肠，颜色表面，肝，胰腺......
[期刊论文] 作者：Maximilian Waldner,Carl C Schimanski,Markus F Neurath,,
来源：World Journal of Gastroenterology 年份：2006
Colon cancer is still one of the leading causes of cancer death worldwide. Although the host immune system has been shown to react against tumor cells, mainly t...
[期刊论文] 作者：Carl C Schimanski,Peter R Galle,Markus Moehler,,
来源：World Journal of Gastroenterology 年份：2008
To review the implication of CXCR4 for gastrointestinal cancer, a “Pubmed” analysis was performed in order to evaluate the relevance of CXCR4 and its ligands...
VEGF-D expression correlates with colorectal cancer aggressiveness and is downregulated by cetuximab
[期刊论文] 作者：Markus Moehler,Christian Frings,Annett Mueller,Ines Gockel,Carl C Schimanski,Stefan Biesterfeld,Peter,
来源：世界胃肠病学杂志（英文版） 年份：2008
AIM: To gain mechanistic insights into the role played by epidermal growth factor receptor (EGFR) in the reg- ulation of vascular endothelial growth factors (VE...
[期刊论文] 作者：hler,Thomas C Wehler,Carl C Schimanski,,
来源：World Journal of Gastroenterology 年份：2016
AIM: To analyze the efficacy of last line sorafenib treatment in colorectal cancer patients. METHODS: All patients receiving chemotherapy for colorectal cancer...
VEGF-D expression correlates with colorectal cancer aggressiveness and is downregulated by cetuximab
[期刊论文] 作者：Markus Moehler,Christian Frings,Annett Mueller,Ines Gockel,Carl C Schimanski,Stefan Biesterfeld, Institute,
来源：World Journal of Gastroenterology 年份：2008
AIM:To gain mechanistic insights into the role played by epidermal growth factor receptor (EGFR) in the regulation of vascular endothelial growth factors (VEGFs...
[期刊论文] 作者：Markus Moehler,Martin F Sprinzl,Murad Abdelfattah,Carl C Schimanski,Bernd Adami,Werner Godderz,Klaus,
来源：World Journal of Gastroenterology 年份：2009
AIM:To investigate the efficacy and safety of capecitabine plus irinotecan±bevacizumab in advanced or metastatic colorectal cancer patients. METHODS:Forty six...
相关搜索：
